Today's most important initiations

Wedbush initiated coverage on Datadog (NASDAQ: DDOG) with an Outperform rating and a price target of $101.00.

Goldman Sachs initiated coverage on PTC Therapeutics (NASDAQ: PTCT) with a Sell rating and a price target of $35.00, noting it believes that maturing key franchises put intermediate term consensus growth assumptions at risk.

Exane BNP Paribas initiated coverage on Equinix (NASDAQ: EQIX) with an Outperform rating and a price target of $886.00.

Raymond James initiated coverage on POINT Biopharma Global Inc. (NASDAQ: PNT) with an Outperform rating and a price target of $10.00.

Goldman Sachs initiated coverage on Xenon Pharmaceuticals (NASDAQ: XENE) with a Buy rating and a price target of $60.00. The analysts see near-to-medium-term stock performance driven primarily by updates on XEN1101 in FOS, which they view as a largely de-risked lead indication.

By Davit Kirakosyan

Want this type of news in real-time as it happens? Upgrade to StreetInsider.com Premium Here

You May Also Be Interested In

• Raymond James Downgrades Phreesia Inc. (PHR) to Market Perform
• Raymond James Upgrades Airbnb Inc. (ABNB) to Outperform
• Ionis Pharmaceuticals (IONS) PT Lowered to $84 at Raymond James